Since inhibition of proteasome increases the VDR protein together with higher stability of VDR in the presence of ligand, especially multiple myeloma (MM) patients, treated with proteasome inhibitor bortezomib, might greatly benefit from vitamin D supplementation. Here, VDR is linked to Miyoshi myopathy.